Dinesh Mondal
Warning message
- Could not find a Solr index corresponding to your website and environment. To fix this problem, please read our documentation.
- Could not find a Solr index corresponding to your website and environment. To fix this problem, please read our documentation.
![]() Senior Scientist (Emeritus) International Centre for Diarrhoeal Disease Research (icddr,b), Bangladesh Email: din63d@icddrb.org
VALIDATE Role: Network Investigator
Research Keywords: NTDs, VBDs, Nutrition, Clinical trial, Diagnostics
Biography: I have been working in visceral leishmaniasis (VL) research since 2006 and have now gained substantial experience in this field. During this time, I have succeeded in building well-trained teams for basic, clinical, diagnostic, vector-ecology and operational research on VL and other NTDs. Many of our novel contributions to VL research have been adopted by the National Programs of VL endemic countries such as single dose liposomal amphotericin B (AmBisome) for treatment of VL in the rural hospitals and early detection of cases with VL and PKDL by different active case detection strategies. For the first time we demonstrated that: diagnosis of VL is feasible by examining peripheral buffy coat smear; Durable Wall Lining is effective for sand fly control; a mass bed-net impregnation program with slow release insecticide tablets is effective for sand fly control and reducing VL burden; insecticidal wall paints is the most powerful tool with longer duration of efficacy for controlling sandflies compared to all existing vector control tools currently; and VL related mortality is high among tribal populations in Bangladesh. We first established that macular cases of PKDL are infectious to sand flies, therefor they must be treated to prevent outbreak of VL; insecticidal wall paints are effective for controlling sand flies; Miltefosine at allometric doses for treatment of PKDL in children and adolescents is safe and effective; PKDL development and VL relapse are related to the different treatment regimens for primary VL; urine antigen detection test for diagnosis of VL and PKDL is highly sensitive and specific; and molecular tools like qPCR and RPA are sensitive for detection of pathogens in sandflies and mosquitoes therefore are excellent tools for xenomonitoring in the post validation phases of elimination of VL and LF, and for early warning of Dengue outbreak as well. Our innovation like mobile suitcase lab for rapid detection of leishmania infection is a real breakthrough in rapid molecular diagnosis of VL and other diseases like Dengue, Malaria and Leptospirosis. All these were possible thanks to the excellent collaboration and financial support from TDR, WHO, Geneva, Switzerland, Bill and Melinda Gates Foundation, NTD, WHO, Geneva, Switzerland, IDRI, Seattle, USA, Thrasher Research Funds, USA, FIND, Geneva, Switzerland, DNDi, Geneva, Switzerland, PATH, India / USA, Liverpool School of Tropical Medicine, UK and University of Leipzig, Germany. Our vision is to develop cost-effective therapeutic and preventive strategies including vaccine against VL and other diseases of public health importance.
Related Websites:
Key Publications:
|